GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Allurion Technologies
Allurion produces and markets a unique, non-surgical, swallowable gastric balloon for weight loss. Its stock price is a bet on the growth of the obesity market. The chart reflects the pace of adoption of this innovative technology.
Share prices of companies in the market segment - Fitness
Allurion Technologies has developed a unique weight loss system—a gastric balloon that is swallowed as a capsule and requires no surgery. We've categorized it under "Fitness." The chart below shows how investors rate innovative bariatric solutions.
Broad Market Index - GURU.Markets
Allurion is a company that has developed and markets a unique, ingestible gastric balloon for weight loss that requires no surgery. As a pioneer, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Allurion's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
ALUR - Daily change in the company's share price Allurion Technologies
Allurion Technologies Inc.'s daily stock price fluctuates reflecting the volatility of the weight-loss equipment sector. The metric is sensitive to demand for its ingestible gastric balloon and competition from pharmaceuticals.
Daily change in the price of a set of shares in a market segment - Fitness
Allurion Technologies Inc. is a company in the obesity treatment field. This chart highlights the high volatility of the MedTech sector. Comparing it to ALUR, with its innovative gastric balloon, helps us understand how its business model is ahead of industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Allurion Technologies has developed a swallowable gastric balloon for weight loss. The stock price of this innovative medical technology company reflects the demand for non-surgical methods for combating obesity. Its price movement reflects the contribution of innovative medicine to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Allurion Technologies
Allurion Technologies' year-over-year performance tells the story of its unique, ingestible gastric balloon for weight loss. Its market cap growth over the past 12 months reflects its success in commercializing this non-invasive procedure globally. Its valuation is a bet that its approach will become a popular alternative to diets and bariatric surgery.
Annual dynamics of market capitalization of the market segment - Fitness
Allurion Technologies offers a unique weight loss program based on an ingestible gastric balloon. The chart below shows how its innovative yet niche product and market expansion efforts impact its performance relative to the medical technology sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Allurion Technologies offers an innovative solution in the hot weight loss market. Its performance compared to the market is a testament to the competition between a non-invasive device and new pharmaceutical blockbusters. Outperforming the market will mean its product finds a sought-after niche among patients and doctors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Allurion Technologies
Allurion is a medical company that has developed a swallowable gastric balloon for weight loss. Its monthly performance reflects the pace of commercialization of its product. The growth in the number of procedures worldwide and quarterly revenue reports are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Fitness
Allurion Technologies has developed a unique weight loss system—a balloon that is swallowed and inflated in the stomach, requiring no surgery. The graph below shows the overall trend in the fitness and health sector, reflecting the huge demand for effective and safe weight loss solutions.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of companies producing medical weight-loss products are driven by consumer spending on health. The chart below shows the overall sentiment. Is Allurion Technologies following these trends, or is its innovative product creating its own demand, independent of the market?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Allurion Technologies
Allurion, the maker of an innovative, non-surgical, swallowable gastric balloon for weight loss, is responding to medical news. Its weekly stock price reflects demand for non-invasive obesity treatments, as well as regulatory approvals in new countries.
Weekly dynamics of market capitalization of the market segment - Fitness
Allurion, like other medical device manufacturers, is dependent on overall trends in the healthcare sector. However, its focus on obesity treatment makes it sensitive to specific trends in this niche. The chart allows you to compare its performance with the MedTech sector average to highlight this difference.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Allurion Technologies, as a healthcare company, can demonstrate defensive qualities. Demand for its weight-loss products is less dependent on economic cycles. However, as a growth company, it is also susceptible to overall market sentiment. The chart will help you assess which of these two forces has the greater impact on ALUR.
Market capitalization of the company, segment and market as a whole
ALUR - Market capitalization of the company Allurion Technologies
Allurion's market capitalization is the story of a non-surgical weight loss method. The company developed a swallowable gastric balloon. Its price chart reflects how investors view this innovation and its competition with new weight loss drugs like Ozempic. It's a bet on a new approach to the fight against obesity.
ALUR - Share of the company's market capitalization Allurion Technologies within the market segment - Fitness
Allurion Technologies has developed a unique weight loss system involving a balloon that is swallowed and filled in the stomach, eliminating the need for endoscopy. Its market share in the fitness and wellness sector reflects this innovation. The chart below demonstrates the relevance of its non-invasive approach in the fight against obesity.
Market capitalization of the market segment - Fitness
Allurion Technologies has developed a swallowable gastric balloon that helps combat obesity without surgery. The graph below shows the market capitalization of the fitness and health sector, reflecting the growing demand for non-invasive and effective weight loss methods.
Market capitalization of all companies included in a broad market index - GURU.Markets
Allurion has developed a unique, ingestible gastric balloon for weight loss that requires no surgery. Its capitalization is a bet on this non-invasive technology. The graph below shows the economic weight of the obesity industry.
Book value capitalization of the company, segment and market as a whole
ALUR - Book value capitalization of the company Allurion Technologies
Allurion's material foundation is its medical device and digital platform. The company's book value reflects its manufacturing capacity for its ingestible gastric balloon for weight loss, as well as its mobile app for patient support. The chart below shows how the company is building its material and digital foundation to combat obesity.
ALUR - Share of the company's book capitalization Allurion Technologies within the market segment - Fitness
Allurion Technologies produces a swallowable weight-loss balloon. Its production lines are its main tangible asset. The S_BCap_Seg chart shows its share of the physical infrastructure of the fitness technology sector.
Market segment balance sheet capitalization - Fitness
Allurion Technologies has developed a swallowable gastric balloon for weight loss. The creation of such medical devices requires certified manufacturing. The book value chart shows the investment in production capacity required to scale this innovative product.
Book value of all companies included in the broad market index - GURU.Markets
Allurion's assets represent a comprehensive weight loss solution. The company's book value reflects its manufacturing capabilities for its ingestible gastric balloon and its digital patient support platform. This provides the foundation for a non-surgical and technologically advanced approach to combating obesity.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Allurion Technologies
Allurion Technologies has developed a swallowable gastric balloon for weight loss that requires no surgery. Its book value is low. Its market capitalization is a measure of its innovative product, patents, and potential in the vast global obesity market.
Market to book capitalization ratio in a market segment - Fitness
Allurion Technologies has developed a swallowable gastric balloon for weight loss. It's an innovative medical product. The chart shows the market premium for its unique and less invasive solution to obesity compared to its assets.
Market to book capitalization ratio for the market as a whole
Allurion Technologies has developed a swallowable gastric balloon for weight loss that requires no surgery. The company's value lies in this revolutionary product. The chart shows the market premium placed on innovations that address the global obesity problem.
Debts of the company, segment and market as a whole
ALUR - Company debts Allurion Technologies
Allurion Technologies, a company offering a comprehensive weight loss solution, is using debt for commercialization and growth. This chart shows how the company is funding the production of its ingestible gastric balloon, as well as investing in marketing and supporting its digital platform for patients and doctors.
Market segment debts - Fitness
Allurion Technologies has developed a swallowable gastric balloon for weight loss that requires no surgery. Commercializing such an innovative medical product requires significant marketing and physician training. This chart shows how the company is funding its global growth.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Allurion Technologies
Allurion Technologies has developed a ingestible gastric balloon for weight loss. This chart shows how the company is funding the commercialization of its unique product. For a medical company with a novel approach to obesity treatment, debt is a way to quickly get to market, but it comes with risks associated with the adoption of the technology by doctors and patients.
Market segment debt to market segment book capitalization - Fitness
Allurion Technologies offers a non-surgical weight loss solution (a gastric balloon). This business straddles the intersection of medicine and consumer fitness products. This chart for the healthcare and fitness sectors illustrates how companies are funding the commercialization of their products, allowing one to evaluate Allurion's strategy.
Debt to book value of all companies in the market
Allurion Technologies has developed and commercialized a non-surgical weight-loss balloon. The weight-loss market is enormous. The debt-to-book-value ratio indirectly reflects consumer confidence, which allows people to invest in their health and appearance.
P/E of the company, segment and market as a whole
P/E - Allurion Technologies
Allurion Technologies has developed a swallowable gastric balloon that aids weight loss without surgery. This graph reflects the vast obesity market. The high value of this indicator suggests that this less invasive and more accessible method is expected to become a popular alternative for millions of people seeking weight loss.
P/E of the market segment - Fitness
Allurion Technologies Inc. represents the medical device sector. This chart shows the average price-to-earnings ratio for this innovative industry. A company's price-to-earnings ratio (P/E) is higher than average, indicating that investors see significant potential in its gastric balloon in the obesity market and are willing to pay a premium for its technology.
P/E of the market as a whole
Allurion Technologies has developed an innovative weight loss system—a gastric balloon that can be swallowed as a capsule without surgery. This graph reflects consumer health spending. The company's valuation depends on the commercial success of this product, its acceptance by doctors and patients, and competition from other obesity treatments.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Allurion Technologies
Allurion Technologies has developed and markets a non-surgical, swallowable gastric balloon for weight loss. The graph shows future revenue expectations, which depend on growing acceptance of this non-invasive procedure among physicians and patients worldwide.
%20P%2FE%20Allurion%20Technologies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Allurion-Technologies&v=1772513712699 "Chart of the company's future (projected) P/E Allurion Technologies")
Future (projected) P/E of the market segment - Fitness
Allurion Technologies has developed a unique weight loss program based on an ingestible gastric balloon that requires no surgery. This chart shows how its future revenue expectations compare to the industry average. Does the market believe in its non-invasive approach to obesity?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Fitness&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Fitness&v=1772513712725 "Future (projected) P/E graph of the market segment - Fitness")
Future (projected) P/E of the market as a whole
Allurion Technologies has developed a swallowable gastric balloon for weight loss that requires no surgery. It's an innovative product in the vast obesity market. The company's success depends on its commercialization and acceptance by doctors, not on general economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513712758 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Allurion Technologies
Allurion Technologies has developed and commercialized a non-surgical gastric balloon for weight loss that is inserted and expelled naturally. The company's revenue is based on the number of procedures performed worldwide. This chart shows how the demand for less invasive obesity treatments is growing and how this impacts its financial performance.
Profit of companies in the market segment - Fitness
Allurion Technologies has developed and commercialized a weight-loss balloon that can be inserted into the stomach without surgery or endoscopy. This chart reflects the profitability of the fitness sector. The company's innovative product offers a new approach to combating obesity. Its commercial success depends on acceptance by doctors and patients worldwide.
Overall market profit
Allurion Technologies has developed and is commercializing a unique gastric balloon for weight loss that requires no surgery. Demand for such procedures depends on consumer disposable income, as they are often not covered by insurance. This overall profitability curve reflects the economic health that determines people's willingness to pay for such services.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Allurion Technologies
Allurion Technologies has developed a non-surgical gastric balloon that aids weight loss. This chart reflects analysts' future revenue expectations, which hinge on the adoption of this technology by patients and doctors worldwide. It demonstrates the market's confidence in the growth of the weight loss market and the potential for less invasive solutions.
%20profit%20of%20the%20company%20Allurion%20Technologies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Allurion-Technologies&v=1772513712835 "Graph of future (projected) profit of the company Allurion Technologies")
Future (predicted) profit of companies in the market segment - Fitness
Allurion Technologies offers a comprehensive weight loss program, including an ingestible and temporarily implantable gastric balloon. This chart shows profitability forecasts for the fitness sector. It reflects the expected growth of the non-surgical obesity treatment market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Fitness&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Fitness&v=1772513712844 "Graph of future (predicted) profits of companies in a market segment - Fitness")
Future (predicted) profit of the market as a whole
Allurion Technologies offers weight loss solutions, including an ingestible gastric balloon. Demand for these procedures depends on consumer disposable income. The forecast for overall market revenue growth, as shown in the graph, indicates rising incomes and people's willingness to spend on improving their quality of life and appearance.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513712877 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Allurion Technologies
Allurion Technologies has developed a swallowable gastric balloon for weight loss that requires no surgery. The company's P/S reflects investors' perceptions of its innovative product, sales growth, and potential in the vast obesity market.
P/S market segment - Fitness
Allurion Technologies has developed and is commercializing a non-surgical gastric balloon for weight loss that is inserted and removed without endoscopy. It is an innovative approach to combating obesity. This chart shows how the market views their unique product and its commercial potential in the vast global weight loss market.
P/S of the market as a whole
Allurion Technologies has developed a swallowable gastric balloon for weight loss that requires no surgery. The company's revenue is growing thanks to demand for non-invasive obesity treatments. This chart illustrates the average revenue estimate, which helps understand the market premium for this innovative medical product.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Allurion Technologies
Allurion Technologies has developed an innovative weight loss system—a swallowable gastric balloon that requires no surgery. This chart reflects investor expectations for future sales of this revolutionary product, which targets the vast and growing obesity market.
%20P%2FS%20Allurion%20Technologies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Allurion-Technologies&v=1772513713004 "The graph of the company's future (projected) P/S Allurion Technologies")
Future (projected) P/S of the market segment - Fitness
Allurion Technologies, Inc. offers a comprehensive weight loss program that includes a balloon that is swallowed and temporarily placed in the stomach, requiring no surgery. This chart shows how the market estimates future sales of its unique product. It compares it to other companies in the fitness and wellness sector, reflecting the demand for non-invasive solutions.
%20P%2FS%20market%20segment%20graph%20-%20Fitness&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Fitness&v=1772513713010 "Future (projected) P/S market segment graph - Fitness")
Future (projected) P/S of the market as a whole
Allurion Technologies has developed and markets a unique gastric balloon for weight loss that requires no surgery. It is a breakthrough product in the vast obesity market. This chart shows the market's aggregate revenue expectations, and ALUR demonstrates how innovative medical devices can change treatment approaches.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513713021 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Allurion Technologies
Allurion Technologies has developed and commercialized a unique non-surgical weight loss system—a gastric balloon that is swallowed as a capsule. This chart shows revenue from sales of this system and related digital weight monitoring tools to clinics and patients worldwide.
Sales of companies in the market segment - Fitness
Allurion Technologies has developed an innovative weight loss system—an ingestible gastric balloon. This graph shows the revenue from sales of its product. It allows investors to track sales trends and assess the success of this non-invasive procedure in the obesity market.
Overall market sales
Allurion Technologies offers a non-surgical weight loss solution (a gastric balloon). Demand for these procedures is highly dependent on discretionary spending. This consumer confidence curve is key for Allurion, as during periods of economic growth, people are more willing to invest in expensive programs to improve their health and appearance.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Allurion Technologies
Allurion Technologies has developed and markets a non-surgical, ingestible gastric balloon for weight loss. The company's revenue forecast depends on demand for its innovative product. This chart shows analysts' estimates of the weight loss market and the commercial potential of its technology.
%20sales%20of%20the%20company%20Allurion%20Technologies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Allurion-Technologies&v=1772513713088 "Schedule of future (projected) sales of the company Allurion Technologies")
Future (projected) sales of companies in the market segment - Fitness
Allurion Technologies has developed and is commercializing a non-surgical weight-loss balloon. This graph reflects projected revenues for the entire fitness and wellness sector. It helps us understand the growing demand for non-invasive weight loss methods, a key driver of Allurion's growth.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Fitness&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Fitness&v=1772513713113 "Schedule of future (projected) sales of companies in the market segment - Fitness")
Future (projected) sales of the market as a whole
Allurion Technologies has developed a non-surgical gastric balloon for weight loss. Demand for its product is driven by the global obesity problem and patient willingness to pay for innovative treatments. This graph of overall consumer expectations reflects the financial confidence that allows people to invest in expensive health improvement procedures.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513713119 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Allurion Technologies
Allurion Technologies has developed and markets a unique, swallowable gastric balloon for weight loss that requires no surgery. This chart shows how the company monetizes its innovation. Profitability depends on sales volume, approvals in new countries, and expansion of its network of partner clinics.
Market segment marginality - Fitness
Allurion Technologies has developed an innovative weight-loss system—a gastric balloon that can be inserted without surgery or endoscopy. This graph shows the average profit margin in the fitness and health technology sector. It helps assess the potential profitability and global market demand for Allurion's revolutionary product.
Market marginality as a whole
Allurion Technologies offers a comprehensive weight loss solution, including an ingestible gastric balloon and a digital support program. The company operates in the vast obesity market. This overall profitability chart shows the economic backdrop, but for Allurion, demographic trends and the effectiveness of its medical approach are more important.
Employees in the company, segment and market as a whole
Number of employees in the company Allurion Technologies
Allurion Technologies has developed and commercialized a unique swallowable gastric balloon for weight loss. The growth of its team, particularly in sales and marketing, reflects its efforts to globally promote this innovative non-surgical procedure. This chart illustrates the scaling of its commercial activities.
Share of the company's employees Allurion Technologies within the market segment - Fitness
Allurion Technologies has developed a unique non-surgical weight loss system—a swallowable gastric balloon. This chart illustrates its innovative contribution to bariatrics. It reflects the number of medical engineers, nutritionists, and patient support specialists working on the development and implementation of this revolutionary obesity treatment method at Allurion.
Number of employees in the market segment - Fitness
Allurion Technologies offers a comprehensive weight loss program based on an ingestible gastric balloon. This chart shows employment in the fitness and wellness sector. Growth in this industry reflects the global obesity problem and the high demand for non-surgical, effective, and safe weight loss methods.
Number of employees in the market as a whole
Allurion Technologies Inc. offers a comprehensive weight loss program that includes an ingestible gastric balloon. Obesity is a global health issue, creating a huge market. This graph illustrates overall employment, and innovative solutions in this field attract significant investment and create jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Allurion Technologies (ALUR)
Allurion Technologies offers an innovative weight loss solution. It combines a medical device and a digital platform. The metrics on this chart reflect how the market values this hybrid approach. These metrics represent the value of patents and the scalability of the IT solution per employee.
%20of%20the%20company%20Allurion%20Technologies%20(ALUR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Allurion-Technologies-ALUR&v=1772513713206 "Chart of market capitalization per employee (in thousands of dollars) of the company Allurion Technologies (ALUR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Fitness
Allurion Technologies offers a comprehensive weight loss solution, including an ingestible gastric balloon. Its market value per employee reflects the value of this innovative medical technology and the supporting digital platform. This high figure indicates significant potential in the obesity market.
%20by%20market%20segment%20-%20Fitness&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Fitness&v=1772513713222 "Market capitalization per employee (in thousands of dollars) by market segment - Fitness")
Market capitalization per employee (in thousands of dollars) for the overall market
Allurion Technologies has developed and commercialized a gastric balloon for weight loss that requires no surgery. It's an innovative product in the vast weight loss industry. This chart shows how the market views this product's potential and the team's ability to scale its sales globally.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513713251 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Allurion Technologies (ALUR)
Allurion Technologies is a medical company that has developed a "gastric balloon" for weight loss that requires no surgery (it's swallowed). This is R&D and marketing. This graph (likely negative) shows how much the company spends per employee (R&D, sales) to convince doctors and patients of the effectiveness of this innovation.
%20Chart%20Allurion%20Technologies%20(ALUR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Allurion-Technologies-ALUR&v=1772513713261 "Company Profit Per Employee (in thousands of dollars) Chart Allurion Technologies (ALUR)")
Profit per employee (in thousands of dollars) in the market segment - Fitness
Allurion Technologies has developed and is commercializing a weight-loss balloon that can be inserted without surgery or endoscopy. This chart illustrates the commercial potential of their innovative product. It demonstrates how effectively the company can monetize its unique solution for combating obesity, generating revenue in the global health market.
%20in%20the%20market%20segment%20-%20Fitness&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Fitness&v=1772513713278 "Chart of profit per employee (in thousands of dollars) in the market segment - Fitness")
Profit per employee (in thousands of dollars) for the market as a whole
Allurion Technologies has developed an innovative weight loss system—a "gastric balloon in a capsule"—that requires no surgery. It's a breakthrough product in both fitness and medicine. This chart shows how successfully the company is commercializing this technology, balancing R&D, manufacturing, and marketing costs with sales revenue.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513713283 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Allurion Technologies (ALUR)
Allurion Technologies offers a non-surgical weight-loss balloon. This chart demonstrates the effectiveness of its product's commercialization. Growing revenue per employee means that more and more clinics and patients worldwide are choosing its technology to combat excess weight, confirming its demand.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Allurion-Technologies-ALUR&v=1772513713387 "Sales chart per company employee Allurion Technologies (ALUR)")
Sales per employee in the market segment - Fitness
Allurion Technologies (ALUR) has developed a "gastric balloon in a capsule"—a non-surgical weight loss method complemented by a digital platform for tracking progress. This chart shows the average revenue per employee in the segment. Comparing Allurion to this benchmark demonstrates how effectively their team is commercializing this innovative weight loss program.
Sales per employee for the market as a whole
Allurion Technologies (ALUR) is a company that produces an ingestible gastric balloon for weight loss. It is a medical device company in the commercialization stage. This metric measures how successfully their sales team promotes this innovative weight loss procedure to doctors and patients worldwide.
Short shares by company, segment and market as a whole
Shares shorted by company Allurion Technologies (ALUR)
Allurion Technologies produces and markets a "gastric balloon" (in the form of a capsule) for the non-surgical treatment of obesity. This chart shows the odds that their product will fail. "Bears" believe that new injectables (Ozempic, Wegovy) will completely destroy the market for devices like Allurion's.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Allurion-Technologies-ALUR&v=1772513713439 "Short Shares Chart for the Company Allurion Technologies (ALUR)")
Shares shorted by market segment - Fitness
Allurion (ALUR) is a medical technology company offering a "swallowable" gastric balloon for weight loss that doesn't require surgery. This chart highlights the pessimism in the sector. The surge in shorts across the industry is a bet that ALUR has lost the "weight loss war." Investors see "miracle injections" (like Ozempic) as making balloon technology obsolete. Why swallow a balloon when you can get an injection?
Shares shorted by the overall market
Allurion Technologies is promoting an innovative "gastric balloon" for weight loss. It's an expensive procedure not covered by insurance. This graph illustrates the rise in general anxiety. When consumers fear for their jobs, spending on non-essential "beauty and health" is the first thing they cut.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Allurion Technologies (ALUR)
This oscillator for Allurion is a barometer of faith in non-surgical weight loss. The company is promoting a "swallowable" gastric balloon, an attractive idea for a huge market. "Overbought" levels (above 70) arise from news of an increase in the number of procedures or approval in new countries. Doubts about long-term effectiveness or competition from drugs (GLP-1) lead to "oversold" levels.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Allurion-Technologies-ALUR&v=1772513713521 "RSI 14 indicator chart for the company's stock Allurion Technologies (ALUR)")
RSI 14 Market Segment - Fitness
Allurion is a "medtech" for weight loss. Their signature feature is a swallowable (non-surgical) gastric balloon. The "fitness" (or, more broadly, weight loss) sector is the epicenter of the hype (especially with GLP-1). RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is ALUR's growth a niche product or a part of the *general* hype?
RSI 14 for the overall market
Allurion, a manufacturer of gastric balloons for weight loss, sees this schedule as a sign of a willingness to spend on "self-improvement." This expensive, elective procedure is pure luxury. In moments of euphoria and the "wealth effect," people readily invest in their appearance. As soon as market panic and austerity strike, these "non-essential" procedures are postponed indefinitely.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ALUR (Allurion Technologies)
Allurion (ALUR) is known for its swallowable gastric balloon (a weight-loss capsule) that requires no surgery. This chart shows the average target price. It reflects analysts' views on the pace of adoption of this procedure and its competition with GLP-1 drugs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ALUR-Allurion-Technologies&v=1772513713616 "A chart showing analyst consensus forecasts for the expected stock price. ALUR (Allurion Technologies)")
The difference between the consensus estimate and the actual stock price ALUR (Allurion Technologies)
Allurion is a wellness company that combats obesity with a unique, ingestible gastric balloon that requires no surgery. This chart shows how the current stock price differs from the "fair" value predicted by analysts. It reflects their belief in the commercialization of this non-invasive technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ALUR-Allurion-Technologies&v=1772513713656 "A chart showing the difference between the consensus forecast and the actual stock price. ALUR (Allurion Technologies)")
Analyst consensus forecast for stock prices by market segment - Fitness
Allurion is a "mechanical Ozempic." The company created the world's first gastric balloon for weight loss that's simply swallowed (no surgery required). It's a MedTech solution to obesity. This chart reflects general expectations for the fitness (and MedTech) sector. It shows whether experts believe in "non-drug" weight loss methods.
Analysts' consensus forecast for the overall market share price
Allurion Technologies is a wellness company that has developed a unique weight-loss product: a gastric balloon that can be swallowed (without surgery). This chart shows overall market sentiment. For Allurion, whose business is focused on expensive, discretionary health care, the overall analyst optimism (the rising chart) is a signal of consumer confidence.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Allurion Technologies
Allurion is weight loss without surgery. Their signature feature is a balloon in a pill: the world's first swallowable gastric balloon, inserted without surgery or anesthesia and then expelled naturally. This chart summarizes their rollout history. It reflects their (slow) progress toward FDA approval and their battle for market share with injections (Ozempic).
AKIMA Market Segment Index - Fitness
Allurion Technologies (ALUR) offers a comprehensive, non-surgical weight loss program. Their flagship product is an ingestible gastric balloon combined with digital coaching. The chart shows the average index for the segment, helping investors assess the demand for this non-invasive fitness and weight loss system compared to the average.
The AKIM Index for the overall market
Allurion Technologies is a weight loss company offering a non-surgical, swallowable gastric balloon. It competes with GLP-1 medications. This chart, which reflects the market average, is a backdrop. It helps assess how ALUR, an alternative to obesity medications, stacks up against overall macroeconomic trends.
